Nasdaq grants Wellgistics Health extension to regain compliance with minimum stockholders’ equity rule
Wellgistics Health Inc WGRX | 0.00 |
- Wellgistics Health received a Nasdaq notice for failing the $2.5 million stockholders’ equity minimum under Listing Rule 5550(b)(1) in its 2025 Form 10-K.
- Stockholders’ equity stood at $(12.45) million as of Dec. 31, 2025, triggering the continued-listing deficiency.
- Nasdaq granted an extension to regain compliance by Oct. 12, 2026, requiring a public filing showing restored equity or pro forma compliance.
- Failure to evidence compliance in its 2026 periodic report could lead to delisting, subject to appeal to a Nasdaq Hearings Panel.
- Nasdaq also closed a separate $1 minimum bid-price deficiency on June 9, 2026, following a compliant trading streak from May 26 to June 8, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028464), on June 12, 2026, and is solely responsible for the information contained therein.
